Democritus University of Thrace (DUTH)
Μελέτη της παθογένειας των ιδιοπαθών διαμέσων πνευμονιών με μικροσυστοιχίες γενετικού υλικού (microarrays)
Abstract
dc:descriptionIdiopathic interstitial pneumonias (IIPs) are a heterogeneous group of diseases comprising of seven distinct clinical and pathological entities. Idiopathic pulmonary fibrosis (IPF) and cryptogenic organizing pneumonia (COP) represent two of the most prevalent members of the disease group with major differences in pathogenesis, clinical course and prognosis. The incidence of IPF is estimated at 6.8-16.3 cases per 100.000 per year in the United States, and the mean survival from the time of diagnosis is 3-5 yr regardless of treatment. IPF is a refractory and lethal IIP characterized by fibroblast proliferation, extracellular matrix deposition and progressive lung scarring, comprising the histopathologic pattern of usual interstitial pneumonia (UIP). In UIP, areas of accumulated fibroblasts and myofibroblasts mainly distributed in subepithelial areas of the intersititium, termed fibroblastic foci represent the pathogenetic hallmark of fibrogenesis. On the other hand, COP, is a patchy process involving alveolar ducts and alveoli, characterized by distinct fibromyxoid lesions called Masson bodies that are susceptible to even complete reversal, in contrast to fibroblastic foci that represent collections of highly proliferative fibroblastic-like cells resistant to apoptosis. These lesions may reflect differential wound repair responses to lung injury; the active fibrosis of IPF mirrors the abnormal wound repair in response to multiple sites of ongoing alveolar epithelial injury, involving increased activity and possibly exaggerated responses by a spectrum of proinflammatory and profibrogenic factors whereas that of COP may reflect normal wound repair response to pulmonary injury. In IPF, due to the lack of a more effective alternative, the fundamental therapeutic approach has been use of corticosteroids, alone or in combination with other immunosuppressive agents; however, this has little impact on long-term survival and is effective only in a minority of affected individuals. While the treatment of IPF remains elusive, COP presents with excellent prognosis and corticosteroid treatment responsiveness. Several studies have attributed these differences to distinct pathogenetic characteristics reflected by regional differences in apoptotic and angiogenic profiles. In an attempt to elucidate pathogenetic differences between these two disease entities and delineate potential mechanisms explaining distinct regional apoptotic and angiogenic profiles we investigated the expression of HIF-1a and telomerase in experimental models of pulmonary fibrosis and in patients with IPF and COP. A. HIF-1a in the pathogenesis of pulmonary fibrosis HIF-1a is recognized as a master regulator of hypoxic signaling by activating gene transcription of genes encoding proteins that mediate the cellular adaptive response under hypoxic conditions. Hypoxia, the lack of oxygen, can modulate alveolar epithelial cell homeostasis by promoting significant and adverse effects on epithelial function, including VEGF and surfactant protein production, disruption of cytoskeleton integrity, and the triggering of apoptosis through induction of p53 expression. Alveolar hypoxia can also promote macrophage recruitment and enhanced expression of inflammatory mediators. Thus, hypoxia could represent a potential fibrotic stimulus through induction of epithelial apoptosis, angiogenesis and modulation of the inflammatory response. With the use of DNA microarrays we performed extensive expression profiling of disease progression in an animal model of the disease, compared our data with all publicly available expression profiles both from human patients and animal models and identified HIF-1a as one of the most deregulated genes. The mRNA levels of HIF-1a, as well as of HIF-1a target gene vegfa, were found upregulated upon administration of bleomycin and the development of pulmonary inflammation and fibrosis. Immunohistochemistry for HIF-1a confirmed overexpression of HIF-1a localizing it mainly at the epithelium. Notably, HIF-1a (and HIF-1 target gene vegfa) overexpression was observed early in the pathologic cascade, before any deterioration of lung architecture and consequent gas exchange problems, indicating an early role for HIF-1 in the development of the modeled disease. Since the bleomycin animal model is not fully representative of IPF due to its self limiting nature and rapidity of its development, we then investigated HIF-1a immunolocalization in lung samples from patients with IPF/UIP and COP/OP, two histopathologic patterns of pulmonary fibrosis with different clinical course and prognosis. We used the pioneering technology of tissue microarrays, which allowed us the simultaneous analysis of up to 250 samples in a single experiment under highly standardized conditions. ...
Degree
thesis:*- Grantor dc:publisher
- Democritus University of Thrace (DUTH)
- Year dc:date
- 2008
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Tzouvelekis, Argyrios
- Τζουβελέκης, Αργύριος
Subjects
dc:subject × 24- Ιδιοπαθείς διάμεσες πνευμονίες
- Ιδιοπαθής πνευμονική ίνωση
- Κρυπτογενής οργανοποιός πνευμονία
- Μικροσυστοιχίες γενετικού υλικού
- Ιστικές μικροσυστοιχίες
- Επαγόμενος από την υποξία παράγοντας 1α
- Υποξία
- Τελομεράση
- Απόπτωση
- Κυτταρική διαφοροποίηση
- Idiopathic interstitial pneumonias
- Idiopathic pulmonary fibrosis (IPF)
- Cryptogenic organizing pneumonia
- DNA microarrays
- Tissue microarrays
- Hypoxia inducible factor 1α
- Hypoxia
- Telomerase
- Apoptosis
- Cellular differentiation
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Medical and Health Sciences
- Basic Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/21064